Microdialysis separately monitors myocardial interstitial myoglobin during ischemia and reperfusion

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 289, Issue 2 58-2, 2005, Pages

  Kitagawa, Hirotoshi ^a   Yamazaki, Toji ^b   Akiyama, Tsuyoshi ^b   Sugimachi, Masaru ^b   Sunagawa, Kenji ^c   Mori, Hidezo ^b  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Infarction; Interstitial space; Membrane permeability

Indexed keywords

LACTIC ACID; MYOGLOBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEART INFARCTION; HEART LEFT VENTRICLE WALL; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; LACTATE BLOOD LEVEL; MALE; MEMBRANE PERMEABILITY; MICRODIALYSIS; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RABBIT;

ANIMALS; BLOOD PRESSURE; GLYCEROL; HEART RATE; LACTIC ACID; MALE; MICRODIALYSIS; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; MYOGLOBIN; RABBITS; SODIUM CYANIDE; TIME FACTORS;

EID: 23744458466     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.01207.2004     Document Type: Article

References (44)

1. Akiyama T, Yamazaki T, and Ninomiya I. In vivo monitoring of myocardial interstitial norepinephrine by dialysis technique. Am J Physiol Heart Circ Physiol 261: H1643-H1647, 1991.
2. Akiyama T, Yamazaki T, and Ninomiya I. Differential regional response of myocardial interstitial noradrenaline levels to coronary occlusion. Cardiovasc Res 27: 817-822, 1993.
3. Askenasy N, Vivi A, Tassini M, Navon G, and Farkas DL. NMR spectroscopic characterization of sarcolemmal permeability during myocardial ischemia and reperfusion. J Mol Cell Cardiol 33: 1421-1433, 2001.
4. Block MI, Said JW, Siegel RJ, and Fishbein MC. Myocardial myoglobin following coronary artery occlusion. An immunohistochemical study. Am J Pathol 111: 374-379, 1983.
5. Camilleri JP, Joseph D, Amat D, and Fabiani JN. Impaired sacrolemmal membrane permeability in reperfused ischemic myocardium. Ultrastructual tracer study. Virchows Arch 388: 69-76, 1980.
6. Delyani JA and Van Wylen GDL. Endocardial and epicardial interstitial purines and lactate during graded ischemia. Am J Physiol Heart Circ Physiol 266: H1019-H1026, 1994.
7. Dominici R, Infusino I, Valente C, Moraschineli I, and Franzini C. Plasma or serum samples: measurements of cardiac troponin T and of other analytes compared. Clin Chem Lab Med 42: 945-951, 2004.
8. Farb A, Kolodgie FD, Jones RM, Jenkins M, and Virmani R. Early detection and measurement of experimental myocardial infarcts with horseradish peroxidase. J Mol Cell Cardiol 25: 343-353, 1993.
9. Flögel U, Gödecke A, Klotz LO, and Schrader J. Role of myoglobin in the antioxidant defense of the heart. FASEB J 18: 1156-1158, 2004.
10. Flögel U, Merx MW, Gödecke A, Decking UKM, and Schrader J. Myoglobin: a scavenger of bioactive NO. Proc Natl Acad Sci USA 98: 735-740, 2001.
11. Heyndrickx GR, Amano J, Kenna T, Fallon JT, Patrick TA, Manders WT, Rogers GG, Rosendorff C, and Vatner SF. Creatine kinase release not associated with myocardial necrosis after short periods of coronary artery occlusion in conscious baboons. J Am Coll Cardiol 6: 1299-1303, 1985.
12. Hillered L, Valtysson J, Enblad P, and Persson L. Interstitial glycerol as a marker for membrane phospholipid degradation in the acutely injured human brain. J Neurol Neurosurg Psychiatry 64: 486-491, 1998.
13. Jurkowitz-Alexander MS, Altschuld RA, Hohl CM, Johnson JD, McDonald JS, Simmonds TD, and Horrocks LA. Cell swelling, blebbing, and death are dependent on ATP depletion and independent of calcium during chemical hypoxia in a glial cell line (ROC-1). J Neuorchem 59: 344-352, 1992.
14. Kawada T, Yamazaki T, Akiyama T, Sato T, Shishido T, Inagaki M, Sugimachi M, and Sunagawa K. Differential acetylcholine release mechanisms in the ischemic and non-ischemic myocardium. J Mol Cell Cardiol 32: 405-414, 2000.
15. Kennergren C, Nyström B, Nyström U, Berglin E, Larsson G, Mantovani V, Lönnroth P, and Hamberger A. In situ detection of myocardial infarction in pig by measurements of asparate aminotransferase (ASAT) activity in the interstitial fluid. Scand Cardiovasc J 31: 343-349, 1997.
16. Kent SP. Diffusion of myoglobin in the diagnosis of early myocardial ischemia. Lab Invest 46: 265-270, 1982.
17. Kent SP. Intracellular diffusion of myoglobin. A manifestation of early cell injury in myocardial ischemia in dogs. Arch Pathol Lab Med 108: 827-830, 1984.
18. Laperche T, Steg PG, Dehoux M, Benessiano J, Grollier G, Aliot E, Mossard JM, Aubry P, Coisne D, Hanssen M, and Iliou MC. A study of biochemical markers of reperfusion early after thrombolysis for acute myocardial infarction. The PERM Study Group Prospective Evaluation of Reperfusion Markers. Circulation 92: 2079-2088, 1995.
19. Le Quellec A, Dupin S, Genissel P, Savin S, Marchand B, and Houin G. Microdialysis probes calibration: gradient and tissue dependent changes in no net flux and reverse dialysis methods. J Pharmacol Toxicol Methods 33: 11-16, 1995.
20. Mair J. Tissue release of cardiac markers: from physiology to clinical applications. Clin Chem Lab Med 37: 1077-1084, 1999.
21. Matsumura K, Jeremy RW, Schaper J, and Becker LC. Progression of myocardial necrosis during reperfusion of ischemic myocardium. Circulation 97: 795-804, 1998.
22. Miura T. Does reperfusion induce myocardial necrosis? Circulation 82: 1070-1072, 1990.
23. Nachlas MM and Shnitka TK. Macroscopic identification of early myocardial infarcts by alterations in dehydrogenase activity. Am J Pathol 42: 379-405, 1963.
24. Nieminen AL, Gores GJ, Wray BE, Tanaka Y, Herman B, and Lemasters JJ. Calcium dependence of bleb formation and cell death in hepatocytes. Cell Calcium 9: 237-246, 1988.
25. Nomoto K, Mori N, Miyamoto J, Shoji T, and Nakamura K. Relationship between sarcolemmal damage and appearance of amorphous matrix densities in mitochondria following occlusion of coronary artery in rats. Exp Mol Pathol 51: 231-242, 1989.
26. Ortmann C, Pfeiffer H, and Brinkmann B. A comparative study on the immunohistochemical detection of early myocardial damage. Int J Legal Med 113: 215-220, 2000.
27. 2 and C in myocardial ischemic reperfusion injury. Am J Physiol Heart Circ Physiol 260: H877-H883, 1991.
28. Remppis A, Scheffold T, Greten J, Haass M, Greten T, Kubler W, and Katus HA. Intracellular compartmentation of troponin T: release kinetics after global ischemia and calcium paradox in the isolated perfused rat heart. J Mol Cell Cardiol 27: 793-803, 1995.
29. Sage MD and Jennings RB. Cytoskeletal injury and subsarcolemmal bleb formation in dog heart during in vitro total ischemia. Am J Pathol 133: 327-337, 1988.
30. Sarrafzadeh AS, Sakowitz OW, Kiening KL, Benndorf G, Lanksch WR, and Unterberg AW. Bedside microdialysis: a tool to monitor cerebral metabolism in subarachnoid hemorrhage patients? Crit Care Med 30: 1062-1070, 2002.
31. Shindo T, Akiyama T, Yamazaki T, and Ninomiya I. Increase in myocardial norepinephrine during a short period of coronary occlusion. J Auton Nerv Syst 48: 91-96, 1994.
32. Shindo T, Akiyama T, Yamazaki T, and Ninomiya I. Regional myocardial interstitial norepinephrine kinetics during coronary occlusion and reperfusion. Am J Physiol Heart Circ Physiol 270: H245-H251, 1996.
33. Shirato C, Miura T, Ooiwa H, Toyofuku T, Wilborn WH, and Downey JM. Tetrazolium artifactually indicates superoxide dismutase-induced salvage in reperfused rabbit heart. J Mol Cell Cardiol 21: 1187-1193, 1989.
34. Spangenthal EJ and Ellis AK. Cardiac and skeletal muscle myoglobin release after reperfusion of injured myocardium in dogs with systemic hypotension. Circulation 91: 2635-2641, 1995.
35. Steenbergen C, Hill ML, and Jennings RB. Volume regulation and plasma membrane injury in aerobic, anaerobic, and ischemic myocardium in vitro. Effects of osmotic cell swelling on plasma membrane integrity. Circ Res 57: 864-875, 1985.
36. Takami H, Matsuda H, Kuki S, Nishimura M, Kawashima Y, Watari H, Furuya E, and Tagawa K. Leakage of cytoplasmic enzymes from rat heart by the stress of cardiac beating after increase in cell membrane fragility by anoxia. Pflügers Arch 416: 144-150, 1990.
37. Van der Laarse A, van der Wall EE, van den Pol RC, Vermeer F, Verheugt FW, Krauss XH, Bar FW, Hermens WT, Willems GW, and Simoons ML. Rapid enzyme release from acutely infarcted myocardium after early thrombolytic therapy: washout or reperfusion damage? Am Heart J 115: 711-716, 1988.
38. Van Kreel BK, van den Veen FH, Willems GM, and Hermens WT. Circulatory models in assessment of cardiac enzyme release in dogs. Am J Physiol Heart Circ Physiol 264: H747-H757, 1993.
39. Van Nieuwenhoven FA, Musters RJ, Post JA, Verkleij AJ, Van der Vusse GJ, and Glatz JF. Release of proteins from isolated neonatal rat cardiomyocytes subjected to simulated ischemia or metabolic inhibition is independent of molecular mass. J Mol Cell Cardiol 28: 1429-1434, 1996.
40. Wiener BJ. Statistical Principles in Experimental Design (2nd ed.). New York: McGraw-Hill, 1971.
41. Wikström G, Ronquist G, Nilsson S, Maripu E, and Waldenström A. Continuous monitoring of energy metabolites using microdialysis during myocardial ischaemia in the pig. Eur Heart J 16: 339-347, 1995.
42. Wittenberg JB and Wittenberg BA. Myoglobin function reassessed. J Exp Biol 206: 2011-2020, 2003.
43. Wu AH. Biochemical markers of cardiac damage: from traditional enzymes to cardiac-specific proteins. IFCC Subcommittee on Standardization of Cardiac Markers (S-SCM). Scand J Clin Lab Invest Suppl 230: 74-82, 1999.
44. Wunderlich C, Flögel U, Gödecke A, Heger J, and Schrader J. Acute inhibition of myoglobin impairs contractility and energy state of iNOS-overexpressing hearts. Circ Res 92: 1352-1358, 2003.